Effects of NSAIDs on the Incidence of Hospitalisations for Renal Dysfunction in Users of ACE Inhibitors

Drug Safety

Volumn 26, Issue 13, 2003, Pages 983-989

  Bouvy, Marcel L ^a   Heerdink, Eibert R ^a   Hoes, Arno W ^b   Leufkens, Hubert G M ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIGOUT AGENT; CORTICOSTEROID; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LOOP DIURETIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; PARACETAMOL; RECOMBINANT ERYTHROPOIETIN; SPIRONOLACTONE; THIAZIDE DIURETIC AGENT;

ADULT; ARTICLE; CONTROLLED STUDY; HOSPITALIZATION; HUMAN; KIDNEY DISEASE; KIDNEY FAILURE; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR;

ADULT; AGED; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CASE-CONTROL STUDIES; COHORT STUDIES; FEMALE; HOSPITALIZATION; HUMANS; INCIDENCE; KIDNEY DISEASES; MALE; MIDDLE AGED;

EID: 0142248201     PISSN: 01145916     EISSN: None     Source Type: Journal    
DOI: 10.2165/00002018-200326130-00006     Document Type: Article

References (20)

1. Dietz R, Nagel F, Osterziel KJ. Angiotensin-converting enzyme inhibitors and renal function in heart failure. Am J Cardiol 1992; 70: 119C-25C
2. Bakris GL, Weir MR. Angiotensin-converting enzyme inhibitor-associated elevations in serum creatinine: is this a cause for concern? Arch Intern Med 2000; 160: 685-93
3. Kalra PA, Kumwenda M, MacDowall P, et al. Questionnaire study and audit of use of angiotensin converting enzyme inhibitor and monitoring in general practice: the need for guidelines to prevent renal failure. BMJ 1999; 318: 234-7
4. Rexrode KM, Buring JE, Glynn RJ, et al. Analgesic use and renal function in men. JAMA 2001; 286: 315-21
5. Perez Gutthann S, Garcia Rodriguez LA, Raiford DS, et al. Nonsteroidal anti-inflammatory drugs and the risk of hospitalisation for acute renal failure. Arch Intern Med 1996; 156: 2433-9
6. Griffin MR, Yared A, Ray WA. Nonsteroidal antiinflammatory drugs and acute renal failure in elderly persons. Am J Epidemiol 2000; 151: 488-96
7. Krummel T, Dimitrov Y, Moulin B, et al. Drug points: acute renal failure induced by topical ketoprofen. BMJ 2000; 320: 93
8. Baraldi A, Ballestri M, Rapana R, et al. Acute renal failure of medical type in an elderly population. Nephrol Dial Transplant 1998; 13 Suppl. 7: 25-9
9. Packer M. Interaction of prostaglandins and angiotensin II in the modulation of renal function in congestive heart failure. Circulation 1988; 77: I64-73
10. Whelton A. Nephrotoxicity of nonsteroidal anti-inflammatory drugs: physiologic foundations and clinical implications. Am J Med 1999; 106 (5B): 13S-24S
11. World Health Organization. International classification of diseases, ninth revision, Clinical Modification (ICD-9). Geneva, Switzerland: World Health Organization, 1977
12. Stürmer T, Erb A. Keller F, et al. Determinants of impaired renal function with use of nonsteroidal anti-inflammatory drugs: the importance of half-life and other medications. Am J Med 2001; 111: 521-7
13. Ahmed A. Interaction between aspirin and angiotensin-converting enzyme inhibitors: should they be used together in older adults with heart failure? J Am Geriatr Soc 2002; 50: 1293-6
14. Lash JP, Gardner C. Effects of ageing and drugs on normal renal function. Coron Artery Dis 1997; 8: 489-94
15. Quan H, Parsons GA, Ghali WA. Validity of information on comorbidity derived from ICD-9 CCM administrative data. Med Care 2002; 40: 675-85
16. Brater DC. Effects of nonsteroidal anti-inflammatory drugs on renal function: focus on cyclooxygenase-2-selective inhibition. Am J Med 1999; 107 (6A): 65S-70S
17. Rossat J, Maillard M, Nussberger J, et al. Renal effects of selective cyclooxygenase-2 inhibition in normotensive salt-depleted subjects. Clin Pharmacol Ther 1999; 66: 76-84
18. Graham MG. Acute renal failure related to high-dose celecoxib. Ann Intern Med 2001; 135: 69-70
19. Ahmad SR, Kortepeter C, Brinker A, et al. Renal failure associated with the use of celecoxib and rofecoxib. Drug Saf 2002; 25 (7): 537-44
20. Noroian G, Clive D. Cyclo-oxygenase-2 inhibitors and the kidney: a case for caution. Drug Saf 2002; 25 (3): 165-72